Alyeska Investment Group’s Revance Therapeutics, Inc. RVNC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-92,417
| Closed | -$2.5M | – | 524 |
|
|
2022
Q3 | $2.5M | Buy |
+92,417
| New | +$2.5M | 0.03% | 302 |
|
|
2020
Q1 | – | Sell |
-398,362
| Closed | -$6.47M | – | 468 |
|
|
2019
Q4 | $6.47M | Buy |
+398,362
| New | +$6.47M | 0.09% | 199 |
|
|
2014
Q4 | – | Sell |
-32,360
| Closed | -$626K | – | 513 |
|
|
2014
Q3 | $626K | Sell |
32,360
-27,640
| -46% | -$535K | 0.01% | 334 |
|
|
2014
Q2 | $2.04M | Buy |
+60,000
| New | +$2.04M | 0.05% | 281 |
|